Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 60.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 112,943 shares of the pharmacy operator’s stock after selling 169,676 shares during the quarter. International Assets Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $1,038,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. TD Asset Management Inc grew its holdings in Walgreens Boots Alliance by 24.9% during the second quarter. TD Asset Management Inc now owns 379,029 shares of the pharmacy operator’s stock worth $4,584,000 after acquiring an additional 75,557 shares during the period. Savant Capital LLC grew its stake in shares of Walgreens Boots Alliance by 59.1% during the 2nd quarter. Savant Capital LLC now owns 69,631 shares of the pharmacy operator’s stock worth $842,000 after purchasing an additional 25,868 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Walgreens Boots Alliance by 1,444.1% in the 2nd quarter. Acadian Asset Management LLC now owns 15,456 shares of the pharmacy operator’s stock valued at $186,000 after purchasing an additional 14,455 shares in the last quarter. Caprock Group LLC acquired a new stake in shares of Walgreens Boots Alliance in the second quarter valued at about $140,000. Finally, Choreo LLC boosted its holdings in Walgreens Boots Alliance by 83.4% during the second quarter. Choreo LLC now owns 87,726 shares of the pharmacy operator’s stock worth $1,016,000 after buying an additional 39,883 shares in the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

NASDAQ WBA opened at $9.22 on Friday. The business’s 50-day moving average price is $9.21 and its 200 day moving average price is $9.92. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $25.63. The company has a market capitalization of $7.96 billion, a PE ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the prior year, the firm posted $0.67 EPS. The company’s revenue was up 5.9% on a year-over-year basis. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 10.85%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -9.99%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, October 23rd. TD Cowen decreased their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Barclays lifted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a report on Wednesday, December 4th. Finally, Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $12.58.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.